U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT06378346) titled 'GU-01: Glycyrrhizin in Prostate Cancer: A Window-of-Opportunity Clinical and Translational Trial' on April 18.
Brief Summary: This is a pilot, randomized, window-of-opportunity treatment trial in which participants with previously untreated prostate cancer (PCa) who are candidates for surgery (radical prostatectomy)
Study Type: Interventional
Condition: Prostate Cancer
Intervention: * Drug: Glycyrrhizin
75mg orally daily
* Other: Glycyrrhizin
150mg orally daily
* Other: Observation
Participants will not receive any Glycyrrhizin
Recruitment Status: Not Yet Recruiting
Published by HT Digital Content Services with permission...